Market Overview:
The global molecular diagnostics systems market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for personalized medicine, and technological advancements in molecular diagnostics systems. Based on type, the global molecular diagnostics systems market is segmented into PCR, hybridization, and DNA sequencing. PCR held the largest share of the global molecular diagnostics systems market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high accuracy and sensitivity as well as low cost as compared to other types of molecular diagnostic tests. Based on application, hospitals accounted for the majority share of the global molecular diagnostics systems market in 2017 and is expected to maintain its dominance during the forecast period owing to rising demand for early diagnosis and treatment of various diseases.
Product Definition:
Molecular diagnostics systems are computer-aided devices that identify and quantify the presence of specific genetic sequences in a patient's DNA. The importance of molecular diagnostics systems is that they can help doctors to more accurately diagnose diseases, which can lead to more effective treatments.
PCR:
Polymerase Chain Reaction (PCR) is a technique used in molecular diagnostics for multiplexed detection and amplification of specific DNA sequences. It is majorly used for the diagnosis of infectious diseases such as HIV, HCV, & HPV. PCR also finds application in genetic research and forensic science.
Hybridization:
Hybridization is the process of genetic recombination between unlike species. It helps in mapping and identifying genes, determining the structure &function of DNA & RNA, and understanding biological processes at a molecular level. Hybridization techniques have wide applications in medical diagnostics for detecting diseases such as cancer, diabetes mellitus among others.
The global hybridization.
Application Insights:
The market is categorized based on application as hospitals and laboratories. Hospitals are estimated to be the largest revenue generating centers owing to an increase in the prevalence of chronic diseases that require a high degree of molecular diagnostic expertise for their diagnosis. This has resulted in an increased focus by various governments towards establishing molecular diagnostics systems within hospitals, resulting in growth for this segment over the forecast period.
Increasing demand from government agencies, research organizations and private clinics coupled with rising investments by companies & institutions are expected to drive growth for this segment over the forecast period. For instance, In November 2017, ThermoFisher Scientific announced about investing approximately USD 80 million during 2018-2020 toward developing new products and services related to genomics analysis solutions that will help meet growing demands across clinical applications including personalized medicine and precision health care.
Regional Analysis:
North America dominated the global molecular diagnostics systems market in 2017. This can be attributed to the presence of key players, increased healthcare spending and awareness about these tests among physicians and patients. In addition, government support for cancer research is another factor that contributes to this regional market share. For instance, according to statistics published by the American Cancer Society in 2018, around 2 million new cases of cancer will be diagnosed in the U.S., with prostate being the most frequent type (otherwise known as malignant) followed by breast cancer amongst women and lung among men.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence of infectious & chronic diseases coupled with rising disposable income & population growth rates especially in India & China due to which there is an urgent need for cost-effective diagnostic solutions that require minimal human intervention/time consumption thus molecular diagnostics fits this bill perfectly providing quick results while saving time.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in molecular diagnostics systems
- Growing number of private and public sector funding initiatives for molecular diagnostics research and development
- Increasing awareness about the benefits of early diagnosis and treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Diagnostics Systems Market Research Report
By Type
PCR, Hybridization, DNA Sequencing
By Application
Hospitals, Laboratories
By Companies
Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Grifols, Siemens Healthcare, Becton, Dickinson and Company, Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation), Biomérieux Sa, Cepheid Inc, Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Diagnostics Systems Market Report Segments:
The global Molecular Diagnostics Systems market is segmented on the basis of:
Types
PCR, Hybridization, DNA Sequencing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Qiagen N.V.
- Roche Diagnostics
- Hologic, Inc.
- Grifols
- Siemens Healthcare
- Becton, Dickinson and Company
- Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
- Biomérieux Sa
- Cepheid Inc
- Abbott Laboratories
Highlights of The Molecular Diagnostics Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR
- Hybridization
- DNA Sequencing
- By Application:
- Hospitals
- Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Diagnostics Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Molecular diagnostics systems are a type of laboratory test that uses DNA or RNA to identify the cause of a disease. Molecular diagnostics can be used to diagnose diseases such as cancer, heart disease, and Alzheimer's.
Some of the major companies in the molecular diagnostics systems market are Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Grifols, Siemens Healthcare, Becton, Dickinson and Company, Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation), Biom©rieux Sa, Cepheid Inc, Abbott Laboratories.
The molecular diagnostics systems market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Molecular Diagnostics Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Molecular Diagnostics Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Molecular Diagnostics Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Molecular Diagnostics Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Molecular Diagnostics Systems Market Size & Forecast, 2018-2028
4.5.1 Molecular Diagnostics Systems Market Size and Y-o-Y Growth
4.5.2 Molecular Diagnostics Systems Market Absolute $ Opportunity
Chapter 5 Global Molecular Diagnostics Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Molecular Diagnostics Systems Market Size Forecast by Type
5.2.1 PCR
5.2.2 Hybridization
5.2.3 DNA Sequencing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Molecular Diagnostics Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Molecular Diagnostics Systems Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Molecular Diagnostics Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Molecular Diagnostics Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Molecular Diagnostics Systems Analysis and Forecast
9.1 Introduction
9.2 North America Molecular Diagnostics Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Molecular Diagnostics Systems Market Size Forecast by Type
9.6.1 PCR
9.6.2 Hybridization
9.6.3 DNA Sequencing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Molecular Diagnostics Systems Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Molecular Diagnostics Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Molecular Diagnostics Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Molecular Diagnostics Systems Market Size Forecast by Type
10.6.1 PCR
10.6.2 Hybridization
10.6.3 DNA Sequencing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Molecular Diagnostics Systems Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Molecular Diagnostics Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Molecular Diagnostics Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Molecular Diagnostics Systems Market Size Forecast by Type
11.6.1 PCR
11.6.2 Hybridization
11.6.3 DNA Sequencing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Molecular Diagnostics Systems Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Molecular Diagnostics Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Molecular Diagnostics Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Molecular Diagnostics Systems Market Size Forecast by Type
12.6.1 PCR
12.6.2 Hybridization
12.6.3 DNA Sequencing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Molecular Diagnostics Systems Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Molecular Diagnostics Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Molecular Diagnostics Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Molecular Diagnostics Systems Market Size Forecast by Type
13.6.1 PCR
13.6.2 Hybridization
13.6.3 DNA Sequencing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Molecular Diagnostics Systems Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Molecular Diagnostics Systems Market: Competitive Dashboard
14.2 Global Molecular Diagnostics Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Qiagen N.V.
14.3.3 Roche Diagnostics
14.3.4 Hologic, Inc.
14.3.5 Grifols
14.3.6 Siemens Healthcare
14.3.7 Becton, Dickinson and Company
14.3.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
14.3.9 Biomérieux Sa
14.3.10 Cepheid Inc
14.3.11 Abbott Laboratories
